Lecanemab is indicated for the treatment of Alzheimer’s Disease... Jun 26
ISD and Biogen will work together to develop ISD's lead compound, ISD 017, which is being developed to treat severe lupus - systemic lupus erythematosus (... Nov 24
-Advertisements-